Franklin FSP Reports Strong Q4 2025 Revenue NA EPS Beats Fed Governor Miran Resigns Voicing Support for Warsh as Next Chair Why UBS Remains Bullish on Gold and Silver Despite PostPeak Pullback Novagold Resources NG Reports Strong Q1 2026 Revenue NA EPS Beats OpenAI Eyes Public Markets AI Leader Prepares for IPO Filing Explosion on Passenger Train in Quetta Injures Over 30 Security Concerns May Impact Pakistans Investment Climate FTSE Russell Rule Change May Accelerate SpaceX Entry into US and Global Indexes Pope Leo XIVs AI Encyclical Stirs Social Media and Market Debate on Ethical Regulation Indias FDI Inflows Surge 17 YoY to 945 Billion in FY202526 Led by Finance and Technology Sectors FTSE 100 Edges Higher as Iran Deal Optimism Tempers Oil Price Surge WillScot Holdings Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures SDST Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase JSM Q1 2026 Earnings Navient Beats EPS Estimates by 2225 Note Price Unchanged Gap Inc Q1 2026 Earnings Earnings Miss Estimates Amid Strategic Transition UVSP Q1 2026 Earnings EPS Surges 15 Above Estimates on Strong Core Operations OCCIO Q1 2026 Earnings Significant EPS Miss Amid Challenging Credit Environment Skyward Specialty Insurance Group SKWD Edges Higher Amid Steady Support NextCure NXTC Plunges Over 22 as Selling Pressure Intensifies MBNKO Preferred Shares Hold Steady Near 2569 Amid Low Volatility Brookfield Finance Inc 450 Perpetual Subordinated Notes BNJ Holds Steady Near Support as Yield Appeal Endures VICI Properties Holds Steady Near 2850 Amid Modest Trading Activity Bilibili BILI Q4 2025 Earnings Beat Revenue NA EPS 194 Electric Vehicles Gain Traction as Fuel Prices Continue to Climb Credit Freeze 101 How to Protect Your Financial Identity in 2026 Pacific PACB Declines 554 Amid Market Weakness 20260513 Wall Street Grows Wary as Fed Rate Hike Concerns Resurface CBS Backs Down from Copyright Enforcement After Stephen Colbert Parody HBANL Q1 2026 Earnings Preferred Dividend Misses Estimates on Higher Provisioning Design Therapeutics DSGN Edges Lower as Stock Tests Support Near 1060